With oral cyclic peptides offering small molecule convenience and antibody‑like selectivity, the modality is gaining momentum ...

Keshav Bhutada, chief executive officer of Shilpa CDMO, said the company has long been recognized among existing partners for its capabilities with challenging molecules such as high-potency APIs ...

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing for Small Molecule APIs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...

Dublin, Aug. 26, 2026 (GLOBE NEWSWIRE)-- The "Small Molecule API Manufacturing Market by Type of Manufacturer, Type of API, API Potency, Scale of Operation, Geographical Regions and Key Players - ...

Developing small molecule drugs is exceptionally challenging. Pharmaceutical companies face high costs, high attrition rates, and significant risks. A particular challenge is getting a small molecule ...